Bristol-Myers Squibb buy klostergang
Start price
08.09.17
/
50%
€56.59
Target price
08.03.18
€67.65
Performance (%)
6.63%
End price
08.03.18
€59.63
Summary
This prediction ended on 08.03.18 with a price of €59.63. The BUY prediction by klostergang finished with a performance of 6.63%. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bristol-Myers Squibb | 4.507% | 4.507% | 13.845% | -18.998% |
| iShares Core DAX® | -2.486% | 0.323% | 0.748% | 51.017% |
| iShares Nasdaq 100 | -4.401% | 1.587% | 32.085% | 87.968% |
| iShares Nikkei 225® | -4.295% | 0.970% | 50.000% | 61.272% |
| iShares S&P 500 | -2.199% | 2.005% | 22.599% | 65.117% |
Comments by klostergang for this prediction
In the thread Bristol-Myers Squibb diskutieren
klostergang stimmt der Buy-Einschätzung von Joe130978 zu
klostergang stimmt am 08.09.2017 der Buy-Einschätzung von Joe130978 mit dem Kursziel 75$ zu.
Überschrift: Bristol-Myers Squipp = Bad news kaufen!!
https://seekingalpha.com/news/3294374-bristol-myers-opdivo-outperforms-docetaxel-treatment-resistant-lung-cancer-patients-late
(Laufzeit überschritten)
Stopped prediction by klostergang for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€41.38
04.01.19
04.01.19
€81.18
04.11.21
04.11.21
33.28%
17.06.21
17.06.21
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€64.20
15.03.15
15.03.15
€68.00
15.09.15
15.09.15
-17.70%
15.09.15
15.09.15